Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 2,816 AGIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Jun 18, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 454 | n/a |
| Jun 10, 2026 | INCYTE CORP (INCY) | Grant/Award | 1,642 | n/a |
| Jun 24, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 203 | n/a |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Jun 12, 2025 | INCYTE CORP (INCY) | Grant/Award | 2,518 | n/a |
| Apr 10, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 15,933 | n/a |
| Mar 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 894 | n/a |
| Jun 24, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/Award | 2,120 | n/a |
| Jun 17, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 3,388 | n/a |